Sarepta Therapeutics | Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.6B 10M 2025-09
Agios Pharmaceuticals USD 1.6B 16M 2026-02
Alnylam Pharmaceuticals USD 39.74B 12.8B 2026-02
Amgen USD 201.45B 25.2B 2026-02
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 27.01B 1.19B 2026-02
BioMarin Pharmaceutical USD 12.21B 1.81B 2026-02
Capricor Therapeutics USD 207M 227M 2025-06
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.01T 3.37B 2026-02
Esperion Therapeutics USD 340M 235M 2023-12
Gilead Sciences USD 183.59B 31.31B 2026-02
Incyte USD 22.7B 3.31B 2026-02
Insmed USD 23.91B 13.21B 2026-02
Ionis Pharmaceuticals USD 10.43B 4.14B 2025-09
Moderna USD 16.5B 6.41B 2026-02
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 13.68B 465M 2026-02
Novavax USD 684M 43M 2023-09
Pfizer USD 152.89B 11.32B 2026-02
PTC Therapeutics USD 5.36B 744M 2026-02
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
Sarepta Therapeutics USD 2.02B 336M 2025-09
Tectonic Therapeutic USD 294M 77M 2025-09
Ultragenyx Pharmaceutical USD 1.94B 284M 2026-02
Vertex Pharmaceuticals USD 120.12B 5.09B 2026-02


Sarepta Therapeutics Kapitalizacja Rynkowa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.